Apotex Health Corp (APTX)
- 37.190
- -0.190-0.51%
Apotex Health Corp (APTX) News
Apotex Health Corp. (APTX) Gets a Buy From RBC Capital
Top News Today/Canada: Manufacturing Sector PMI Rises in July
Apotex Health Corp Price Target Raised to C$40.00/Share From C$36.00 by Raymond James
Press Release: Apotex Receives Investment Grade Issuer Rating From Morningstar DBRS and Announces Amended & Restated Credit Agreement
Apotex Receives Investment Grade Issuer Rating From Morningstar DBRS And Announces Amended & Restated Credit Agreement >APTX.T
Canaccord Genuity Initiates Coverage On Apotex Health With Buy Rating, Announces Price Target of C$42
Apotex Health Corp. Price Target Announced at C$42.00/Share by Canaccord Genuity
Apotex Health Corp Price Target Raised to C$43.00/Share From C$39.00 by BMO Capital Markets
Fine, Kaplan and Black, R.P.C. Anuncia Que Ya Se Aceptan Formularios De Reclamación Para Los Acuerdos De Demanda Colectiva Si Pagó O Recibió Un Reembolso Por Determinados Medicamentos Genéricos Recetados En Estados Unidos Entre El 1 De Mayo De...
Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
Apotex Health Initiated at Outperformer, C$40 Price Target at CIBC
Apotex Health Corp.: Largest Canadian Pharma's Strengthened Balance Sheet and Growth Platform Support Buy Rating and C$40 Price Target
Health Care Roundup: Market Talk
Apotex Health's Success in the Canadian Generic Drug Market Can Continue -- Market Talk
Apotex Health Corp Initiated at Buy by TD
Apotex Health Corp. Initiated at Buy by Bloom Burton
Apotex Health Corp Initiated at Outperform by ATB Cormark
Apotex Health Corp. Price Target Announced at C$40.00/Share by Bloom Burton
Apotex Health Corp. Initiated at Buy by Desjardins Securities
Apotex Health Corp. Price Target Announced at C$40.00/Share by Desjardins Securities